Maria Sundvall

A metabolic prosurvival role for PML in breast cancer

Arkaitz Carracedo, Dror Weiss, Amy K. Leliaert et al. · Journal of Clinical Investigation · 2012 · 272 citations · Full text

Life Sciences, Cancer Biology, Oncology +17

Signaling via ErbB2 and ErbB3 Associates with Resistance and <i>Epidermal Growth Factor Receptor</i> (<i>EGFR</i>) Amplification with Sensitivity to EGFR Inhibitor Gefitinib in Head and Neck Squamous Cell Carcinoma Cells

Kaisa Erjala, Maria Sundvall, Teemu T. Junttila et al. · Clinical Cancer Research · 2006 · 265 citations · Full text

Medicine, Oncology, Pharmacology +17

Cleavable ErbB4 Isoform in Estrogen Receptor–Regulated Growth of Breast Cancer Cells

Teemu T. Junttila, Maria Sundvall, Mikael Lundin et al. · Cancer Research · 2005 · 188 citations

Medicine, Molecular Biology, Oncology +16

A Natural ErbB4 Isoform That Does Not Activate Phosphoinositide 3-Kinase Mediates Proliferation but Not Survival or Chemotaxis

Varpu Kainulainen, Maria Sundvall, Jorma A. Määttä et al. · Journal of Biological Chemistry · 2000 · 163 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +14

Proteolytic Cleavage and Phosphorylation of a Tumor-associated ErbB4 Isoform Promote Ligand-independent Survival and Cancer Cell Growth

Jorma A. Määttä, Maria Sundvall, Teemu T. Junttila et al. · Molecular Biology of the Cell · 2005 · 142 citations · Full text

Medicine, Molecular Biology, Oncology +17